Cart
sales@molnova.com
Home - Products - GPCR/G Protein - 5-HT Receptor - Landipirdine

Landipirdine

CAS No. 1000308-25-7

Landipirdine( RO-5025181 | SYN-120 )

Catalog No. M10003 CAS No. 1000308-25-7

A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 561 In Stock
10MG 753 In Stock
25MG 1216 In Stock
50MG 1516 In Stock
100MG 2158 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Landipirdine
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.
  • Description
    A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.Parkinson's DiseasePhase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RO-5025181 | SYN-120
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    Neurological Disease
  • Indication
    Parkinson Disease

Chemical Information

  • CAS Number
    1000308-25-7
  • Formula Weight
    362.419
  • Molecular Formula
    C18H19FN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(N)NC[C@@H]1CCCC2=C1C=CC(S(=O)(C3=CC=CC(F)=C3)=O)=C2
  • Chemical Name
    N-(((1R)-6-(3-fluorobenzenesulfonyl)-1,2,3,4-tetrahydronaphthalen-1-yl)methyl)urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Huot P, et al. ACS Chem Neurosci. 2017 May 17;8(5):973-986.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Tedatioxetine hydrob...

    Tedatioxetine hydrobromide (Lu AA 24530 hydrobromide) is a serotonin-norepinephrine-dopamine reuptake inhibitor and an antagonist of 5-HT2A, 5-HT2C, 5-HT3, and α1A-adrenergic receptors, which can be used to treat depression and anxiety.

  • Minesapride

    Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.

  • SB 243213

    SB 243213 is an orally available and selective 5-HT2C receptor antagonist.SB 243213 has anxiolytic and antidepressant activity and is used in schizophrenia and movement disorders.

Sign In Join Free